479 related articles for article (PubMed ID: 27451124)
1. H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.
Nichol JN; Dupéré-Richer D; Ezponda T; Licht JD; Miller WH
Adv Cancer Res; 2016; 131():59-95. PubMed ID: 27451124
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination.
Ezponda T; Licht JD
Clin Cancer Res; 2014 Oct; 20(19):5001-8. PubMed ID: 24987060
[TBL] [Abstract][Full Text] [Related]
3. PRC2-independent chromatin compaction and transcriptional repression in cancer.
Vallot C; Hérault A; Boyle S; Bickmore WA; Radvanyi F
Oncogene; 2015 Feb; 34(6):741-51. PubMed ID: 24469045
[TBL] [Abstract][Full Text] [Related]
4. H3K27 methylation: a promiscuous repressive chromatin mark.
Wiles ET; Selker EU
Curr Opin Genet Dev; 2017 Apr; 43():31-37. PubMed ID: 27940208
[TBL] [Abstract][Full Text] [Related]
5. Context-specific regulation of cancer epigenomes by histone and transcription factor methylation.
Sarris M; Nikolaou K; Talianidis I
Oncogene; 2014 Mar; 33(10):1207-17. PubMed ID: 23503463
[TBL] [Abstract][Full Text] [Related]
6. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
Zheng Y; He L; Wan Y; Song J
Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Retinal Development via the Epigenetic Modification of Histone H3.
Watanabe S; Murakami A
Adv Exp Med Biol; 2016; 854():635-41. PubMed ID: 26427469
[TBL] [Abstract][Full Text] [Related]
8. Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic intervention.
Shen C; Vakoc CR
Curr Opin Oncol; 2015 Jan; 27(1):57-63. PubMed ID: 25402979
[TBL] [Abstract][Full Text] [Related]
9. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
Komar D; Juszczynski P
Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
[TBL] [Abstract][Full Text] [Related]
10. The see-saw of differentiation: tipping the chromatin balance.
Muegge K; Xi S; Geiman T
Mol Interv; 2008 Feb; 8(1):15-8, 2. PubMed ID: 18332479
[TBL] [Abstract][Full Text] [Related]
11. [A primer for epigenetics of hematological malignancies].
Nakajima H
Rinsho Ketsueki; 2016; 57(10):1835-1844. PubMed ID: 27725578
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanism of survivin dysregulation in human cancer.
Lyu H; Huang J; He Z; Liu B
Sci China Life Sci; 2018 Jul; 61(7):808-814. PubMed ID: 29318497
[TBL] [Abstract][Full Text] [Related]
13. Differential remodeling of mono- and trimethylated H3K27 during porcine embryo development.
Park KE; Magnani L; Cabot RA
Mol Reprod Dev; 2009 Nov; 76(11):1033-42. PubMed ID: 19536841
[TBL] [Abstract][Full Text] [Related]
14. JMJD3 as an epigenetic regulator in development and disease.
Burchfield JS; Li Q; Wang HY; Wang RF
Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
Christofides A; Karantanos T; Bardhan K; Boussiotis VA
Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053
[TBL] [Abstract][Full Text] [Related]
16. Compendium of aberrant DNA methylation and histone modifications in cancer.
Hattori N; Ushijima T
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
[TBL] [Abstract][Full Text] [Related]
17. The growing role of epigenetics in childhood cancers.
Panditharatna E; Filbin MG
Curr Opin Pediatr; 2020 Feb; 32(1):67-75. PubMed ID: 31895160
[TBL] [Abstract][Full Text] [Related]
18. H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation.
Harutyunyan AS; Chen H; Lu T; Horth C; Nikbakht H; Krug B; Russo C; Bareke E; Marchione DM; Coradin M; Garcia BA; Jabado N; Majewski J
Cell Rep; 2020 Nov; 33(7):108390. PubMed ID: 33207202
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
Biswas S; Rao CM
Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]